Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial

Adam J Ritchie, Omary Hassan, Nsiande Urasa, Paschal A Apanga, Rinter Kimathi, Wilmina F Kalinga, Ivanny M Mtaka, Reward G Lyimo, Moshi Moshi Shabani, Francisco Orliacq, Adam Berg, ZhiQuan Xiang, Saumu Ahmed, Thabit Athuman, Hildegund C J Ertl, Ally Olotu, Alexander D Douglas, Rose Paul Mkumbange, Ibrahim Sasamalo, Aina-Ekisha Kahatano, Safiness Daudi Mchome, Bakari Mwalimu Bakari, Neema Balige, Hania Msami, Mohamed Mohamed, Egbert Stanslaus Kenya

Open source

DOI
10.1016/s1473-3099(26)00071-x
Published
2026-08
Container
The Lancet Infectious Diseases
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1473-3099-26-00071-x,
  title = {Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial},
  author = {Adam J Ritchie and Omary Hassan and Nsiande Urasa and Paschal A Apanga and Rinter Kimathi and Wilmina F Kalinga and Ivanny M Mtaka and Reward G Lyimo and Moshi Moshi Shabani and Francisco Orliacq and Adam Berg and ZhiQuan Xiang and Saumu Ahmed and Thabit Athuman and Hildegund C J Ertl and Ally Olotu and Alexander D Douglas and Rose Paul Mkumbange and Ibrahim Sasamalo and Aina-Ekisha Kahatano and Safiness Daudi Mchome and Bakari Mwalimu Bakari and Neema Balige and Hania Msami and Mohamed Mohamed and Egbert Stanslaus Kenya},
  year = {2026},
  journal = {The Lancet Infectious Diseases},
  doi = {10.1016/s1473-3099(26)00071-x},
  url = {https://doi.org/10.1016/s1473-3099(26)00071-x}
}

RIS

TY  - JOUR
TI  - Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial
AU  - Adam J Ritchie
AU  - Omary Hassan
AU  - Nsiande Urasa
AU  - Paschal A Apanga
AU  - Rinter Kimathi
AU  - Wilmina F Kalinga
AU  - Ivanny M Mtaka
AU  - Reward G Lyimo
AU  - Moshi Moshi Shabani
AU  - Francisco Orliacq
AU  - Adam Berg
AU  - ZhiQuan Xiang
AU  - Saumu Ahmed
AU  - Thabit Athuman
AU  - Hildegund C J Ertl
AU  - Ally Olotu
AU  - Alexander D Douglas
AU  - Rose Paul Mkumbange
AU  - Ibrahim Sasamalo
AU  - Aina-Ekisha Kahatano
AU  - Safiness Daudi Mchome
AU  - Bakari Mwalimu Bakari
AU  - Neema Balige
AU  - Hania Msami
AU  - Mohamed Mohamed
AU  - Egbert Stanslaus Kenya
PY  - 2026
JO  - The Lancet Infectious Diseases
DO  - 10.1016/s1473-3099(26)00071-x
UR  - https://doi.org/10.1016/s1473-3099(26)00071-x
ER  - 

APA

Ritchie, A. J., Hassan, O., Urasa, N., Apanga, P. A., Kimathi, R., Kalinga, W. F., Mtaka, I. M., Lyimo, R. G., Shabani, M. M., Orliacq, F., Berg, A., Xiang, Z., Ahmed, S., Athuman, T., Ertl, H. C. J., Olotu, A., Douglas, A. D., Mkumbange, R. P., Sasamalo, I., Kahatano, A., Mchome, S. D., Bakari, B. M., Balige, N., Msami, H., Mohamed, M., & Kenya, E. S. (2026). Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(26)00071-x

Source records